Kawther Alquadan, MD
Chronic disease →Telehealth platform
Independent
Session types
Video & Phone & Messaging
Languages
English
(352) 273-8822
Are you Kawther Alquadan, MD?
Claim your profile to verify your insurance, update your bio, add your booking link, and get a Verified badge that builds patient trust. Free tier goes live instantly — no card required.
Claim your profileLooking for a patient? Here's what to know
This profile shows public registry data — name, specialty, and licensed states are confirmed via the federal NPI database. Insurance accepted, current bio, and booking links haven't been confirmed by Kawther yet. To verify if they take your insurance or are accepting new patients, contact their practice directly.
About
Dr. Kawther Alquadan specializes in managing complex chronic diseases, helping patients achieve better disease control and improved quality of life through personalized treatment plans. With expertise in conditions like diabetes, hypertension, and COPD, she works with patients to optimize their medication regimens and lifestyle modifications via convenient telehealth visits. Dr. Alquadan is committed to empowering patients to take an active role in their long-term health management and prevent disease progression.
Services offered
Dr. Alquadan provides comprehensive telehealth management for patients with chronic medical conditions including diabetes, hypertension, heart disease, asthma, COPD, and thyroid disorders. She evaluates patients through detailed history and assessment of current symptoms, medication effectiveness, and lifestyle factors that impact disease control. Her treatment approach integrates evidence-based medication management with patient education on diet, exercise, stress management, and medication adherence to achieve sustained health improvements. Typical telehealth sessions include vital sign review, symptom assessment, medication optimization, lab result interpretation, and collaborative goal-setting to help patients prevent complications and maintain independence.